Leberzirrhose und Nierenfunktionsstörungen

  • H. Geiger
  • U. Leuschner


Das hepatorenale Syndrom (HRS) ist ein funktionelles Nierenversagen bei Patienten mit Zirrhose, die keine eigenständige Nierenkrankheit haben. Das HRS ist charakterisiert durch eine Gefäß-Konstriktion der Nierenrinde, die zur Oligurie und Natriumretention führt. Patienten mit Leberzirrhose und Aszites entwickeln zu 18% innerhalb eines Jahres ein funktionelles Nierenversagen, nach 5 Jahren sogar zu 39%.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Angeli P, Volpin R, Gerunda G, et al., (1999) Reversal of type I hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 29:1690–1697PubMedCrossRefGoogle Scholar
  2. Arroyo V, Gines P, Gerbes AL, et al., (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23:164–176PubMedCrossRefGoogle Scholar
  3. Badalamenti S, Graziani G, Salerno F, Ponticelli C (1993) Hepatorenal syndrome: new perspectives in pathogenesis and treatment. Arch Intern Med 153:1957–1967PubMedCrossRefGoogle Scholar
  4. Brensing KA, Textor J, Strunk H, et al., (1997) Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet 349:697–698PubMedCrossRefGoogle Scholar
  5. Caregaro L, Menon F, Angeli P, et al., (1994) Limitation of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 154:201–205PubMedCrossRefGoogle Scholar
  6. Davison AM (1996) Hepatorenal failure. Nephrol Dial Transplant 11[Suppl 8]: 24–31PubMedCrossRefGoogle Scholar
  7. Epstein M (1994) Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy. J Am Soc Nephrol 4:1735–1753PubMedGoogle Scholar
  8. Flint A (1863) Clinical report on hydro-peritoneum, based on an analysis of forty-six cases. Am J Med Sci 45:306–339CrossRefGoogle Scholar
  9. Geiger H, Klepper J, Lux P, Heidland A, Sterzel RB (1992) Biochemical assessment and clinical estimation of a bilirubin adsorbent column (BR-350) in critically ill patients with intractable jaundice. Int J Artif Organs 15:35–39PubMedGoogle Scholar
  10. Gentilini P, Romanelli RG, La Villa G, et al., (1993) Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. Gastroenterology 104:588–594PubMedGoogle Scholar
  11. Ginès A, Escorsell A, Ginès P, et al., (1993) Incidence, predictive factors, and prognosis of the hepatorenal syndrome with ascites. Gastroenterology 105:229–236PubMedGoogle Scholar
  12. Ginès P, Arroyo V (1999) Hepatorenal syndrome. J Am Soc Nephrol 10:1833–1839PubMedGoogle Scholar
  13. Guevara M, Gines P, Bandi JC, et al., (1998a) Transjugular intrahepatic portosystemic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 28:416–422PubMedCrossRefGoogle Scholar
  14. Guevara M, Ginès P, Fernandez-Esparrach G, et al., (1998b) Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 27:35–41PubMedCrossRefGoogle Scholar
  15. Holt S, Goodier D, Marley R, et al., (1999) Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet 353:294–295PubMedCrossRefGoogle Scholar
  16. Jeyarajah DR, Gonwa TA, McBride M, et al., (1997) Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant. Transplantation 64:1760–1765PubMedCrossRefGoogle Scholar
  17. Lieberman FL, Denison EK, Reynolds RB (1970) The relationship of plasma volume, portal hypertension, ascites and renal sodium retention in cirrhosis: the overflow theory of ascites formation. Ann NY Acad Sci 170:202–208CrossRefGoogle Scholar
  18. Mandai AK, Lansing M, Fahmy A (1982) Acute tubular necrosis in hepatorenal syndrome: an electron microscopy study. Am J Kidney Dis 2:363–374Google Scholar
  19. Rees CJ, Rose JD, Record CO, et al., (1997) Transjugular intrahepatic portosystemic shunt: a limited role in refractory ascites. Eur J Gastroenterol Hepatol 9:969–973PubMedCrossRefGoogle Scholar
  20. Sort P, Navasa M, Arroyo V, et al., (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341:403–409PubMedCrossRefGoogle Scholar
  21. Stange J, Mitzner SR, Risler T, et al., (1999) Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 23:319–330PubMedCrossRefGoogle Scholar
  22. Wrenger E, Brunkhorst R, Malfertheimer P, Neumann KH (1998) Das hepatorenale Syndrom. Intensivmedizin 35:390–400CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • H. Geiger
  • U. Leuschner

There are no affiliations available

Personalised recommendations